Orthofix International Announces the Launch of the FORZA Spinal Spacer System

Thu Oct 25, 2012 9:00am EDT

* Reuters is not responsible for the content in this press release.

Orthofix International Announces the Launch of the FORZA™ Spinal Spacer System

Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today the introduction of the FORZA™ Spinal Spacer System. This next generation, bulleted PLIF/TLIF spacer offers several unique features, including chamfered edges that offer the surgeon the ability to rotate the implant as needed.

“The launch of FORZA™ represents our revitalized commitment to introducing new products in our strategic markets,” said Robert Vaters, President and Chief Executive Officer. “With a return to investing in research and development, we believe our improving product offering of Repair Implants along with our Regenerative Biologics and Stimulation solutions provide a Value Proposition that is unmatched in the industry.”

The FORZA™ Spacer System features uniquely designed instruments that improve surgical efficiency during a PLIF or TLIF technique. The modular inserter allows the surgeon to choose their preference of either holding it 90 degrees, 45 degrees, or straight.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development
markquick@orthofix.com